Table 1 Clinical, epidemiological, and angiographic profile of patients with Takayasu arteritis
Variables | n = 30 (%) |
|---|---|
Age | 42.6 ± 13.2 |
Sex | |
Female | 25 (83.3) |
Time of Diagnosis | 7.5 (3.0–16.6)** |
Immunosuppressive Drugs | n (%) |
Azathioprine | 4 (13.3) |
Methotrexate | 4 (13.3) |
Prednisone | 2 (6.7) |
Methotrexate/Azathioprine | 1 (3.3) |
Methotrexate/Prednisone | 12 (40.0) |
None | 7 (23.3) |
Angiographic Classification of HATA | |
Type I | 2 (6.7) |
Type IIA | 5 (16.7) |
Type IIB | 1 (3.3) |
Type III | 3 (10.0) |
Type IV | 2 (6.7) |
Type V | 17 (56.7) |
Cluster Classification | |
I | 6 (20.0) |
II | 16 (53.3) |
III | 8 (26.7) |